Sierra Summit Advisors LLC Purchases New Shares in Tenet Healthcare Corporation $THC

Sierra Summit Advisors LLC bought a new position in Tenet Healthcare Corporation (NYSE:THC) in the third quarter, HoldingsChannel reports. The firm bought 3,770 shares of the company’s stock, valued at approximately $765,000.

Several other large investors have also modified their holdings of THC. WCM Investment Management LLC increased its stake in Tenet Healthcare by 244.4% in the third quarter. WCM Investment Management LLC now owns 510,224 shares of the company’s stock worth $102,657,000 after purchasing an additional 362,083 shares during the period. AlphaQuest LLC boosted its position in Tenet Healthcare by 238.3% in the 3rd quarter. AlphaQuest LLC now owns 5,965 shares of the company’s stock valued at $1,211,000 after buying an additional 4,202 shares during the period. Winnow Wealth LLC bought a new stake in shares of Tenet Healthcare during the third quarter valued at approximately $1,129,000. Cerity Partners LLC increased its holdings in Tenet Healthcare by 10.4% during the 2nd quarter. Cerity Partners LLC now owns 120,623 shares of the company’s stock worth $21,230,000 after purchasing an additional 11,395 shares during the period. Finally, Savant Capital LLC lifted its holdings in shares of Tenet Healthcare by 27.5% in the 3rd quarter. Savant Capital LLC now owns 16,894 shares of the company’s stock worth $3,430,000 after buying an additional 3,647 shares during the period. Hedge funds and other institutional investors own 95.44% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have commented on the stock. Royal Bank Of Canada raised their target price on shares of Tenet Healthcare from $253.00 to $277.00 and gave the company an “outperform” rating in a research report on Thursday, February 12th. TD Cowen reaffirmed a “buy” rating on shares of Tenet Healthcare in a research report on Thursday, February 12th. Barclays upped their price objective on Tenet Healthcare from $240.00 to $257.00 and gave the stock an “overweight” rating in a research note on Friday, February 13th. Leerink Partners increased their price target on shares of Tenet Healthcare from $255.00 to $264.00 and gave the company an “outperform” rating in a research report on Friday, February 20th. Finally, JPMorgan Chase & Co. boosted their price objective on shares of Tenet Healthcare from $200.00 to $230.00 and gave the stock an “overweight” rating in a research note on Thursday, November 13th. One analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $247.67.

Insider Buying and Selling

In other news, Director Nadja West sold 2,178 shares of the stock in a transaction on Monday, December 15th. The shares were sold at an average price of $197.47, for a total value of $430,089.66. Following the sale, the director owned 28,480 shares in the company, valued at $5,623,945.60. This represents a 7.10% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 0.81% of the company’s stock.

Tenet Healthcare Stock Performance

Shares of Tenet Healthcare stock opened at $238.68 on Monday. The company has a quick ratio of 1.68, a current ratio of 1.76 and a debt-to-equity ratio of 2.18. Tenet Healthcare Corporation has a 52 week low of $109.82 and a 52 week high of $240.83. The firm has a market capitalization of $20.76 billion, a P/E ratio of 15.41, a PEG ratio of 1.18 and a beta of 1.39. The company has a 50 day moving average price of $206.02 and a 200 day moving average price of $200.15.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings data on Wednesday, February 11th. The company reported $4.70 EPS for the quarter, topping the consensus estimate of $4.08 by $0.62. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The business had revenue of $5.53 billion during the quarter, compared to the consensus estimate of $5.47 billion. During the same period in the previous year, the firm posted $3.44 earnings per share. The business’s revenue for the quarter was up 8.9% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. Sell-side analysts expect that Tenet Healthcare Corporation will post 12.24 EPS for the current year.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.